COCRYSTAL PHARMA NEW O.N. Market Cap ($13.54 Million)
Market Cap & Net Worth: COCRYSTAL PHARMA NEW O.N. (8CC)
COCRYSTAL PHARMA NEW O.N. market cap. COCRYSTAL PHARMA NEW O.N. (F:8CC) has a market capitalization of $13.54 Million (€11.58 Million) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #26140 globally and #2238 in its home market, demonstrating a 4.35% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying COCRYSTAL PHARMA NEW O.N.'s stock price €0.84 by its total outstanding shares 13785759 (13.79 Million). Also see cash efficiency ratio of COCRYSTAL PHARMA NEW O.N. for how efficiently the company converts equity into cash flow.
COCRYSTAL PHARMA NEW O.N. Market Cap History (2020–2026)
COCRYSTAL PHARMA NEW O.N. market cap history from 2020 to 2026. Data shows change from $220.48 Million to $13.54 Million (-31.76% CAGR). Check COCRYSTAL PHARMA NEW O.N. (8CC) share price today for real-time trading data and today's change.
COCRYSTAL PHARMA NEW O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how COCRYSTAL PHARMA NEW O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore COCRYSTAL PHARMA NEW O.N. net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 8CC by Market Capitalization
Companies near COCRYSTAL PHARMA NEW O.N. in the global market cap rankings as of November 3, 2026. Also see 8CC asset base for a full breakdown of the balance sheet.
Key companies related to COCRYSTAL PHARMA NEW O.N. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of COCRYSTAL PHARMA NEW O.N. (2020–2026)
Market capitalization of COCRYSTAL PHARMA NEW O.N. from 2020 to today. Between 2020 and today, COCRYSTAL PHARMA NEW O.N.'s market cap moved from $220.48 Million to $ 13.54 Million, with a yearly change of -31.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €13.54 Million | +4.35% |
| 2025 | €12.97 Million | -72.24% |
| 2024 | €46.74 Million | +87.10% |
| 2023 | €24.98 Million | -9.88% |
| 2022 | €27.72 Million | -74.40% |
| 2021 | €108.31 Million | -50.88% |
| 2020 | €220.48 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of COCRYSTAL PHARMA NEW O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.54 Million USD |
| MoneyControl | $13.54 Million USD |
| MarketWatch | $13.54 Million USD |
| marketcap.company | $13.54 Million USD |
| Reuters | $13.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About COCRYSTAL PHARMA NEW O.N.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hep… Read more